FDA Approves First Generics for Vyvanse

August 28, 2023 -- FDA has approved several first generics of Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets for attention-deficit/hyperactivity disorder (ADHD) in patients six years and older and moderate to severe binge-eating...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news